Dallas R. Brown

发表

First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adults.

N. Waters, Z. Beck, G. Matyas, 2022, Vaccine.

ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type

D. Montefiori, D. Venzon, G. Alter, 2019, PLoS pathogens.

Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants

Gregory D. Gromowski, N. Michael, G. Matyas, 2022, Vaccines.

HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition

D. Montefiori, R. Koup, D. Venzon, 2018, Nature Medicine.

Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type

D. Montefiori, D. Venzon, G. Alter, 2019, PLoS pathogens.

Restricted valency (NPNA)n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum

Z. Beck, G. Matyas, A. Batchelor, 2022, NPJ vaccines.

Therapeutic cardiac arrest as an adjunct to resuscitative endovascular balloon occlusion of the aorta: Bridging the gap from fatal hemorrhage to definitive surgical control in swine.

S. Cardin, J. Glaser, Kyle S. Stigall, 2021, The journal of trauma and acute care surgery.

Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition

F. Barrenäs, D. Montefiori, S. Santra, 2020, PLoS pathogens.

Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate

J. Berzofsky, R. Koup, M. Roederer, 2019, Front. Immunol..